메뉴 건너뛰기




Volumn 364, Issue 9451, 2004, Pages 2076-2077

A functional autoantibody in human narcolepsy?

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOMODULATING AGENT; OREXIN;

EID: 10344239398     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17562-4     Document Type: Note
Times cited : (2)

References (13)
  • 1
    • 0037309268 scopus 로고    scopus 로고
    • The neurobiology, diagnosis, and treatment of narcolepsy
    • Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol. 53:2003;154-166
    • (2003) Ann Neurol , vol.53 , pp. 154-166
    • Scammell, T.E.1
  • 2
    • 0344444257 scopus 로고    scopus 로고
    • Hypocretins/orexins and narcolepsy: From molecules to disease
    • Peyron C, Charnay Y. Hypocretins/orexins and narcolepsy: from molecules to disease. Rev Neurol 2003; 159 (suppl 11): 6 s35-41.
    • (2003) Rev Neurol , vol.159 , Issue.6 SUPPL. II
    • Peyron, C.1    Charnay, Y.2
  • 3
    • 7044221981 scopus 로고    scopus 로고
    • In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients
    • Lodi R, Tonon C, Vignatelli L, et al. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients. Neurology. 63:2004;1513-1515
    • (2004) Neurology , vol.63 , pp. 1513-1515
    • Lodi, R.1    Tonon, C.2    Vignatelli, L.3
  • 4
    • 0033710848 scopus 로고    scopus 로고
    • Reduced number of hypocretin neurons in human narcolepsy
    • Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27:2000;469-474
    • (2000) Neuron , vol.27 , pp. 469-474
    • Thannickal, T.C.1    Moore, R.Y.2    Nienhuis, R.3
  • 5
    • 0034846670 scopus 로고    scopus 로고
    • Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy
    • Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 50:2001;381-388
    • (2001) Ann Neurol , vol.50 , pp. 381-388
    • Nishino, S.1    Ripley, B.2    Overeem, S.3
  • 6
    • 0035956531 scopus 로고    scopus 로고
    • CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
    • Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology. 57:2001;2253-2258
    • (2001) Neurology , vol.57 , pp. 2253-2258
    • Ripley, B.1    Overeem, S.2    Fujiki, N.3
  • 7
    • 0035524415 scopus 로고    scopus 로고
    • Immunological aspects of narcolepsy
    • Carlander B, Dauvilliers Y, Billiard M. Immunological aspects of narcolepsy. Rev Neurol. 157:(11 Pt 2):2001;S97-100
    • (2001) Rev Neurol , vol.157 , Issue.11 PART 2 , pp. 97-100
    • Carlander, B.1    Dauvilliers, Y.2    Billiard, M.3
  • 8
    • 0031830681 scopus 로고    scopus 로고
    • A case of multiple sclerosis with initial symptoms of narcolepsy
    • Wang CY, Kawashima H, Takami T, et al. A case of multiple sclerosis with initial symptoms of narcolepsy. No To Hattatsu. 30:1998;300-306
    • (1998) No to Hattatsu , vol.30 , pp. 300-306
    • Wang, C.Y.1    Kawashima, H.2    Takami, T.3
  • 9
    • 0346787768 scopus 로고    scopus 로고
    • Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult
    • Lagrange AH, Blaivas M, Gomez-Hassan D, Malow BA. Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult. Epilepsy Behav. 4:2003;788-792
    • (2003) Epilepsy Behav , vol.4 , pp. 788-792
    • Lagrange, A.H.1    Blaivas, M.2    Gomez-Hassan, D.3    Malow, B.A.4
  • 10
    • 3042792719 scopus 로고    scopus 로고
    • Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity
    • Boehmer LN, Wu MF, John J, Siegel JM. Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Exp Neurol. 188:2004;292-299
    • (2004) Exp Neurol , vol.188 , pp. 292-299
    • Boehmer, L.N.1    Wu, M.F.2    John, J.3    Siegel, J.M.4
  • 11
    • 4043153396 scopus 로고    scopus 로고
    • Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep
    • Gerashchenko D, Shiromani PJ. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Res. 1019:2004;162-169
    • (2004) Brain Res , vol.1019 , pp. 162-169
    • Gerashchenko, D.1    Shiromani, P.J.2
  • 12
    • 0033948273 scopus 로고    scopus 로고
    • Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome
    • Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum. 43:2000;1647-1654
    • (2000) Arthritis Rheum , vol.43 , pp. 1647-1654
    • Waterman, S.A.1    Gordon, T.P.2    Rischmueller, M.3
  • 13
    • 1542287387 scopus 로고    scopus 로고
    • Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes
    • Jackson MW, Gordon TP, Waterman SA. Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology. 126:2004;819-828
    • (2004) Gastroenterology , vol.126 , pp. 819-828
    • Jackson, M.W.1    Gordon, T.P.2    Waterman, S.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.